PH24214A - Lipid regulating composition - Google Patents
Lipid regulating compositionInfo
- Publication number
- PH24214A PH24214A PH37055A PH37055A PH24214A PH 24214 A PH24214 A PH 24214A PH 37055 A PH37055 A PH 37055A PH 37055 A PH37055 A PH 37055A PH 24214 A PH24214 A PH 24214A
- Authority
- PH
- Philippines
- Prior art keywords
- lipid regulating
- regulating composition
- lipid
- regulating
- bezafibrate
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 150000002632 lipids Chemical class 0.000 title abstract 2
- 230000001105 regulatory effect Effects 0.000 title abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- HEMJJKBWTPKOJG-UHFFFAOYSA-N Gemfibrozil Chemical compound CC1=CC=C(C)C(OCCCC(C)(C)C(O)=O)=C1 HEMJJKBWTPKOJG-UHFFFAOYSA-N 0.000 abstract 1
- 239000003741 agents affecting lipid metabolism Substances 0.000 abstract 1
- 229960000516 bezafibrate Drugs 0.000 abstract 1
- IIBYAHWJQTYFKB-UHFFFAOYSA-N bezafibrate Chemical compound C1=CC(OC(C)(C)C(O)=O)=CC=C1CCNC(=O)C1=CC=C(Cl)C=C1 IIBYAHWJQTYFKB-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229960001214 clofibrate Drugs 0.000 abstract 1
- KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 abstract 1
- 229960002297 fenofibrate Drugs 0.000 abstract 1
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 abstract 1
- 229960003627 gemfibrozil Drugs 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S260/00—Chemistry of carbon compounds
- Y10S260/47—Poisons, foods, or pharmaceuticals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Fats And Perfumes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/061,641 US4859703A (en) | 1987-06-15 | 1987-06-15 | Lipid regulating compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH24214A true PH24214A (en) | 1990-04-10 |
Family
ID=22037126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH37055A PH24214A (en) | 1987-06-15 | 1988-06-10 | Lipid regulating composition |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4859703A (de) |
| EP (1) | EP0295637B1 (de) |
| JP (1) | JPS6419016A (de) |
| AT (1) | ATE67663T1 (de) |
| AU (1) | AU602769B2 (de) |
| DE (1) | DE3865102D1 (de) |
| DK (1) | DK323388A (de) |
| NZ (1) | NZ224669A (de) |
| PH (1) | PH24214A (de) |
| ZA (1) | ZA883623B (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2602423B1 (fr) * | 1986-08-08 | 1989-05-05 | Ethypharm Sa | Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede |
| US5422372A (en) * | 1990-04-10 | 1995-06-06 | The Trustees Of Columbia University In The City Of New York | Method of increasing intracellular accumulation of hydrophilic anionic agents using gemfibrizol |
| EP0462067A1 (de) * | 1990-06-15 | 1991-12-18 | Warner-Lambert Company | Gemfibrozil-Formulierung |
| AU2546892A (en) * | 1991-08-19 | 1993-03-16 | Trustees Of Columbia University In The City Of New York, The | Method of increasing intracellular accumulation of hydrophilic anionic agents using gemfibrizol |
| US7071174B1 (en) * | 1994-10-13 | 2006-07-04 | Cv Therapeutics, Inc. | Method and composition for inhibiting cholesterol esterase |
| FR2730231B1 (fr) * | 1995-02-02 | 1997-04-04 | Fournier Sca Lab | Association de fenofibrate et de vitamine e, utilisation en therapeutique |
| US6713043B2 (en) * | 1996-02-29 | 2004-03-30 | The Trustees Of Columbia University In The City Of New York | Antimicrobial activity of gemfibrozil |
| FR2758459B1 (fr) * | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
| GB2329334A (en) * | 1997-09-18 | 1999-03-24 | Reckitt & Colmann Prod Ltd | Cholesterol-lowering agents |
| US6719999B2 (en) * | 1999-03-31 | 2004-04-13 | Abbott Laboratories | Formulations comprising lipid-regulating agents |
| US6531291B1 (en) | 1999-11-10 | 2003-03-11 | The Trustees Of Columbia University In The City Of New York | Antimicrobial activity of gemfibrozil and related compounds and derivatives and metabolites thereof |
| US6531158B1 (en) * | 2000-08-09 | 2003-03-11 | Impax Laboratories, Inc. | Drug delivery system for enhanced bioavailability of hydrophobic active ingredients |
| GB2373438A (en) * | 2001-02-10 | 2002-09-25 | Reckitt & Colmann Prod Ltd | Cholesterol lowering compositions |
| US7259186B2 (en) * | 2002-12-17 | 2007-08-21 | Abbott Laboratories | Salts of fenofibric acid and pharmaceutical formulations thereof |
| CN101480384A (zh) * | 2002-12-17 | 2009-07-15 | 阿伯特有限及两合公司 | 包含非诺贝酸、其生理可接受的盐或衍生物的制剂 |
| US20080051411A1 (en) * | 2002-12-17 | 2008-02-28 | Cink Russell D | Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof |
| US20080152714A1 (en) * | 2005-04-08 | 2008-06-26 | Yi Gao | Pharmaceutical Formulations |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB860303A (en) * | 1958-06-20 | 1961-02-01 | Ici Ltd | Pharmaceutical compositions comprising ª‡-aryloxy-aliphatic carboxylic acids and/or ª |
| US3674836A (en) * | 1968-05-21 | 1972-07-04 | Parke Davis & Co | 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof |
| US3907792A (en) * | 1969-01-31 | 1975-09-23 | Andre Mieville | Phenoxy-alkyl-carboxylic acid derivatives and the preparation thereof |
| GB1348642A (en) * | 1970-10-15 | 1974-03-20 | Howard A N | Hypocholesterolaemic compositions |
| US3781327A (en) * | 1970-12-10 | 1973-12-25 | Stauffer Chemical Co | Meta-carbanilate ethers |
| BE792421A (fr) * | 1971-12-11 | 1973-06-07 | Merck Patent Gmbh | Agent pour le traitement des hyperlipoproteinemies et son procede de preparation |
| NZ191762A (en) * | 1978-10-19 | 1982-09-14 | Merck & Co Inc | Hypocholesteremic composition containing cholesterol synthesis inhibitor and anion exchange resin |
| US4751026A (en) * | 1986-03-24 | 1988-06-14 | Warner-Lambert Company | Substituted anilides of oleic, linoleic, or linolenic acid as inhibitors of acyl-coa:cholesterol acyltransferase |
-
1987
- 1987-06-15 US US07/061,641 patent/US4859703A/en not_active Expired - Fee Related
-
1988
- 1988-05-17 NZ NZ224669A patent/NZ224669A/xx unknown
- 1988-05-19 AU AU16419/88A patent/AU602769B2/en not_active Ceased
- 1988-05-20 ZA ZA883623A patent/ZA883623B/xx unknown
- 1988-06-10 PH PH37055A patent/PH24214A/en unknown
- 1988-06-14 JP JP63144907A patent/JPS6419016A/ja active Pending
- 1988-06-14 DK DK323388A patent/DK323388A/da not_active Application Discontinuation
- 1988-06-14 DE DE8888109491T patent/DE3865102D1/de not_active Expired - Fee Related
- 1988-06-14 AT AT88109491T patent/ATE67663T1/de not_active IP Right Cessation
- 1988-06-14 EP EP88109491A patent/EP0295637B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK323388D0 (da) | 1988-06-14 |
| AU1641988A (en) | 1988-12-15 |
| ATE67663T1 (de) | 1991-10-15 |
| ZA883623B (en) | 1990-01-31 |
| NZ224669A (en) | 1990-06-26 |
| AU602769B2 (en) | 1990-10-25 |
| EP0295637A2 (de) | 1988-12-21 |
| US4859703A (en) | 1989-08-22 |
| DE3865102D1 (de) | 1991-10-31 |
| EP0295637B1 (de) | 1991-09-25 |
| DK323388A (da) | 1988-12-16 |
| JPS6419016A (en) | 1989-01-23 |
| EP0295637A3 (en) | 1990-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH24214A (en) | Lipid regulating composition | |
| GR3007225T3 (de) | ||
| ES2042725T3 (es) | Procedimiento para preparar inhibidores de 5-alfa-estersa de esteroide. | |
| ES2044840T3 (es) | Composiciones estabilizadas del activador del plasminogeno de tejido humano. | |
| DE3070189D1 (en) | Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it | |
| IL84790A (en) | Pharmaceutical compositions containing 3)-deoxythymidin-2)-ene (3)-deoxy-2), 3)-didehydrothymidine) for treating patients infected with retroviruses | |
| AU1866888A (en) | Pharmaceutical dosage unit containing 17beta-oestradiol and desogestrel | |
| EP0305890A3 (en) | Use of bezafibrate for the treatment of diabetes | |
| AU2234588A (en) | Administration of extremely low dosages of dideoxynucleoside analogs for treating or preventing AIDS in subjects | |
| DK166343C (da) | Forbedret piroxicamholdigt laegemiddel | |
| DE3766885D1 (en) | Chlorpheniramine therapie. | |
| IL75186A0 (en) | Biologically active agents containing substituted isoxazolidines,certain such novel compounds and their preparation | |
| EP0472033A3 (en) | 3,5-diiod-l-thyronin for tsh-suppression and the treatment of goiter | |
| AU575892B2 (en) | Tounge shaped pharmaceutical unit | |
| GR3007110T3 (de) | ||
| ES2122005T3 (es) | Medicamento que contiene (-)-metrifonato. | |
| ATE18408T1 (de) | 11beta-chlor-delta15-steroide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
| IL77624A (en) | Synergistic insecticidal composition containing an enantiomer-pair of cypermethrin,novel enantiomeric mixtures thereof and process for their preparation | |
| Akman | Hacettepe Bulletin of Medicine Surgery | |
| JPS57175194A (en) | 10b-carboxy-aminoboran and physiologically available salts of same, manufacture and use as neutron catching treatment medicine | |
| ES292751U (es) | Un elemento de union para la fijacion de tejidos oseos |